MedTrace Logo

ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)

NCT06371820 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 13000000

Last updated 2024-04-17

No results posted yet for this study

Summary

The ESPRESSO study is a collection of data from all computerised gastrointestinal histopathology reports in Sweden. This allows us to study risk factors for gastrointestinal disease, as well as the prognosis of gastrointestinal disease.

A review of the study has been published here:

https://pubmed.ncbi.nlm.nih.gov/30679926/

Conditions

  • Gastrointestinal Diseases

Interventions

OTHER

ESPRESSO [The study has no intervention]

This study has no interventions.

Sponsors & Collaborators

Principal Investigators

  • Jonas F Ludvigsson, MD, PhD · Karolinska Institutet

Eligibility

Min Age
0 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1965-01-01
Primary Completion
2043-05-17
Completion
2043-05-17

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06371820 on ClinicalTrials.gov